William Blair Investment Management LLC boosted its stake in Repligen Corporation (NASDAQ:RGEN - Free Report) by 57.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,243,415 shares of the biotechnology co...